Position in ELAN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$65,857,589
-$6,790,443 QoQ
Shares Held
2,676,050
-11.9% QoQ
Ownership
0.536%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#34
of 515 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 93%
None 7%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $2,155,261,599 across 33 Drug Manufacturers - Specialty & Generic names. ELAN ranks #6 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,379,025 | $747,197,111 | |
| 2 | ZTS |
Zoetis Inc.
|
9,423,895 | $677,201,094 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,671,157 | $259,898,795 | |
| 4 | ALKS |
Alkermes plc.
|
2,814,804 | $147,495,727 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
1,013,063 | $112,389,207 | |
| 6 | ELAN |
Elanco Animal Health Inc
This page
|
2,676,050 | $65,857,589 | |
| 7 | HLN |
Haleon plc
|
3,273,583 | $30,542,527 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
2,365,103 | $18,731,613 |
All Filings in ELAN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,857,589 | 2,676,050 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $72,648,032 | 3,035,856 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $31,474,821 | 1,390,845 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $25,879,778 | 1,284,994 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $20,247,311 | 1,417,879 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $40,845,587 | 3,890,056 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $48,363,075 | 3,993,648 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $58,874,654 | 4,007,805 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $48,503,311 | 3,361,283 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $58,597,480 | 3,599,354 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $87,151,303 | 5,849,081 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $70,035,515 | 6,230,918 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $67,891,566 | 6,748,665 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $59,405,731 | 6,319,759 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $60,782,301 | 4,974,002 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $59,841,500 | 4,822,039 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $98,109,499 | 4,997,937 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $137,101,459 | 5,254,943 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $563,634,088 | 19,860,257 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $731,797,078 | 22,947,541 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $754,941,227 | 21,762,503 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $582,380,078 | 19,775,215 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $577,837,703 | 18,840,486 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $592,558,325 | 21,215,837 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $535,785,153 | 24,978,329 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $680,588,379 | 30,396,980 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||